Neoadjuvant Chemotherapy With Capecitabine Plus Cisplatin in Patients With Locally Advanced Nasopharyngeal Cancer: Case Series Study.

about

Neoadjuvant Chemotherapy With Capecitabine Plus Cisplatin in Patients With Locally Advanced Nasopharyngeal Cancer: Case Series Study.

Item

http://www.wikidata.org/entity/Q46499242

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Neoadjuvant Chemotherapy With ...... eal Cancer: Case Series Study.

@en

Neoadjuvant Chemotherapy With ...... eal Cancer: Case Series Study.

@nl

type

Item

label

Neoadjuvant Chemotherapy With ...... eal Cancer: Case Series Study.

@en

Neoadjuvant Chemotherapy With ...... eal Cancer: Case Series Study.

@nl

prefLabel

Neoadjuvant Chemotherapy With ...... eal Cancer: Case Series Study.

@en

Neoadjuvant Chemotherapy With ...... eal Cancer: Case Series Study.

@nl

P1476

Neoadjuvant Chemotherapy With ...... eal Cancer: Case Series Study.

@en

P2093

Jamal Zekri

http://www.w3.org/2001/XMLSchema#string

Mohamed El Sayed

http://www.w3.org/2001/XMLSchema#string

Reyad Dada

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised co

Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials

Phase II study of capecitabine and cisplatin combination as first-line chemotherapy in Chinese patients with metastatic nasopharyngeal carcinoma.

Phase II trial of capecitabine plus cisplatin as first-line therapy in patients with metastatic nasopharyngeal cancer.

Bevacizumab with 5-fluorouracil, leucovorin, and oxaliplatin versus bevacizumab with capecitabine and oxaliplatin for metastatic colorectal carcinoma: results of a large registry-based cohort analysis.

Phase II study of capecitabine as palliative treatment for patients with recurrent and metastatic squamous head and neck cancer after previous platinum-based treatment.

Epstein-Barr virus-encoded microRNA BART1 induces tumour metastasis by regulating PTEN-dependent pathways in nasopharyngeal carcinoma

Capecitabine: a review.

Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck.

Phase II trial of cisplatin and capecitabine in patients with squamous cell carcinoma of the head and neck, and correlative study of angiogenic factors.

P304

455-458

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JGO.2016.006924

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29094083

http://www.w3.org/2001/XMLSchema#string

P932

5646894

http://www.w3.org/2001/XMLSchema#string